MAY 08, 2020 11:16 AM PDT

Vaccine Prevents Virally-induced Type 1 Diabetes

WRITTEN BY: Kara Marker

Scientists aren’t exactly sure what causes type 1 diabetes, although genetics and environmental factors are presumed to be involved. One factor that’s suspected is viral infection, and researchers are moving forward with human clinical trials for a vaccine to prevent virally-induced type 1 diabetes.

Approximately 1.6 million Americans are currently living with type 1 diabetes. Researchers saw a 21 percent increase in the prevalence of type 1 diabetes in individuals under age 20 between 2001 and 2009. Unlike type 2 diabetes, type 1 diabetes is an autoimmune disease characterized by an attack on pancreatic beta cells, which produce insulin that’s needed for storing glucose in cells.

Scientific observations, autopsy observations, and epidemiological studies have together pointed to enterovirus infections as a potential factor leading to the development of type 1 diabetes. Enteroviruses constitute a common group of viruses, and one family of particular interest is the Coxsackie B (CVB) family. Six different strains belong to this viral family, causing anywhere from the common cold to myocarditis and meningitis in the worst-case scenario.

In the past, researchers observed over many years the potential involvement of CVB infection with type 1 diabetes through the analysis of blood samples taken from children with a genetic risk profile for type 1 diabetes. Now, researchers from the current study developed a vaccine that could provide protection from all six CVB strains.

The new vaccine candidate has been tested in mice, where it successfully provided protection from virally-induced type 1 diabetes, and rhesus monkeys – with a genetic profile similar to humans – where researchers observed the production of antibodies to CVB, suggesting viral protection. Human clinical trials of the vaccine are imminent. Upon confirming safety in human use, researchers could deploy the vaccine in children with a genetic risk profile for type 1 diabetes.

"It would be fantastic if the cases of type 1 diabetes that we currently suspect are caused by the Coxsackievirus could be prevented, though it's impossible right now to say what percentage of type 1 diabetes cases would be effected,” explained corresponding author Malin Flodström-Tullberg. “At the same time, the vaccine would give protection against myocarditis, which can have a more severe course in both children and adults, and against many kinds of cold, which keep many people away from school and work."

Sources: University of Jyväskylä, Scientific Advances, JDRF, National Institute of Diabetes and Digestive and Kidney Diseases

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate ...
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Critical Interleukin Leads to Drug Discovery
The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
The Antibody Test to See if You've Already Had the Coronavirus
Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiol ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
MAY 03, 2020
Microbiology
MAY 03, 2020
Understanding How Lyme Disease Persists in the Body
Lyme disease is a confounding illness that can be difficult to diagnose, and can cause a wide range of serious health pr ...
MAY 26, 2020
Immunology
MAY 26, 2020
The Hunt for Rare Immune Cells, to InfinityFlow and Beyond
The immune landscape is staggeringly complex, with a myriad of genetically and functionally distinct immune cell subpopu ...
Loading Comments...